SHAREHOLDER ALERT: Rigrodsky Law, PA Announces Investigation of Millendo Therapeutics, Inc. Merger

Published Apr 05 2021 at 4:26 PM GMT
  • WILMINGTON, Del., April 05, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, PA announces that it is investigating Millendo Therapeutics, Inc.
  • ("Millendo") (NASDAQ GS: MLND) regarding possible breaches of fiduciary duties and other violations of law related to Millendo's agreement to merge with Tempest Therapeutics, Inc.


  • Published Apr 5, 2021 4:26 PM GMT